The Drivers of National Innovative Capacity: Implications for Spain and Latin America

Michael E. Porter; Jeffrey L. Furman; Scott  Stern

Working Paper | HBS Working Paper Series | 2000

The Drivers of National Innovative Capacity: Implications for Spain and Latin America

by Michael E. Porter, Jeffrey L. Furman and Scott Stern

Abstract

In the past decade, both academic scholars and policymakers have focused increasing attention on the central role that technological innovation plays in economic growth. There are at least two distinct reasons for this increased interest. First, though economists have long recognized the centrality of technological innovation in microeconomic and macroeconomic processes (Schumpeter, 1950; Solow, 1956; Abramovitz, 1956), leading models and frameworks for understanding economic growth and national competitiveness did not directly incorporate the economic drivers of the innovation process until the late 1980s and early 1990s (Romer, 1990; Porter, 1990; Nelson, 1993). At the same time, the dramatic political changes wrought by the end of the Cold War and the globalization of economic activity have increased the salience of productivity growth as a principal goal of policymakers across the OECD. In turning their attention to the sources and consequences of technological innovation, the academic and policy communities confront a striking empirical puzzle: while R&D activity is relatively dispersed around the world, "new-to-the-world" innovation tends to be concentrated in a few countries at a given point in time. For example, during the 1970s and the early 1980s, only Switzerland, a relatively small but very technology-intensive country, achieved a per capita "international" patenting rate comparable to the rate achieved by U.S. inventors.

Language: English

Format: Print

31 pages

Read Now

Citation:

Porter, Michael E., Jeffrey L. Furman, and Scott Stern. "The Drivers of National Innovative Capacity: Implications for Spain and Latin America." Harvard Business School Working Paper, No. 01-004, May 2000.

Since its establishment in 2005, Hamburg’s Martini Klinik had single-mindedly focused on prostate cancer care with a commitment to measure long term health outcomes for every patient. A wholly owned subsidiary of the University Hospital Hamburg, Martini Klinik was a “hospital in a hospital” in close proximity to other medical departments and services. By 2019, Martini Klinik had become the largest prostate cancer treatment program in the world with 8,000 outpatient cases and more than 2,500 surgical cases annually. Patients came from all over Germany and from around the world. A new and expanded facility was under construction to have the capacity to manage more patients with prostate cancer.

We are entering a new stage of understanding of the linkage between investment performance and social impact. Previous approaches, such as socially responsible investing and environmental, social, and governance (ESG) screening, have obscured the opportunities for higher growth, profitability, and competitive advantage that come from creating shared value: addressing social and environmental issues as integral to a company’s core strategic positioning. A shared value approach to investing can deliver superior shareholder returns, but capturing that value will require very different practices on the part of both corporate leaders and investors.

Faculty & Research

The Drivers of National Innovative Capacity: Implications for Spain and Latin America

Abstract

Citation:

About the Author

More from the Author